This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Cigna (CI) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Cigna (CI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's How Much You'd Have If You Invested $1000 in Cigna a Decade Ago
by Zacks Equity Research
Holding on to popular or trending stocks for the long-term can make your portfolio a winner.
Molina Healthcare (MOH) Up 14.4% in 6 Months: Growth Ahead?
by Zacks Equity Research
Molina Healthcare (MOH) is likely to keep growing on the back of increasing membership and higher premium revenues.
Humana (HUM) to Buy Back Shares of $1B to Add Shareholder Value
by Zacks Equity Research
Humana (HUM) to buy back shares worth $1 billion as part of its $3-billion share repurchase plan announced in February 2021. This suggests its commitment toward delivering a long-term shareholder value.
Here's Why You Should Retain Cigna (CI) in Your Portfolio
by Zacks Equity Research
Cigna (CI) is well-poised for growth, attributable to solid segmental contributions, the continuous launch of affordable MA plans, a strong partner network and sufficient cash reserves.
Top Stock Reports for Exxon Mobil, Sony & Estee Lauder
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil Corporation (XOM), Sony Group Corporation (SONY), and The Estee Lauder Companies Inc. (EL).
UnitedHealth (UNH) Unit Invests to Improve Members' Eye Health
by Zacks Equity Research
UnitedHealth Group's (UNH) business, UnitedHealthcare, offers discount programs and invests in school districts in an effort to improve the eye health of its vision members.
Humana (HUM) Enhances Value-Based Care With Vancouver Clinic
by Zacks Equity Research
Humana (HUM) collaborates with Vancouver Clinic to boost its Medicare Advantage portfolio.
Is First Trust Health Care AlphaDEX ETF (FXH) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for FXH
Why Buying Molina Healthcare (MOH) is a Prudent Move Now?
by Zacks Equity Research
Molina Healthcare's (MOH) total revenues for 2021 are anticipated to be no less than $27.5 billion.
Cigna (CI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $225.89, marking a +1.6% move from the previous day.
Should You Invest in the First Trust Health Care AlphaDEX ETF (FXH)?
by Zacks Equity Research
Sector ETF report for FXH
Cigna (CI), SRHS Tie Up to Offer Enhanced Care in Upstate SC
by Zacks Equity Research
Cigna (CI) inks a deal to expand ties with SRHS. The move equips both healthcare providers to jointly offer enhanced healthcare services across the Upstate community.
Teladoc (TDOC) Ties Up to Offer Virtual Care for NLA Members
by Zacks Equity Research
Teladoc Health (TDOC) teams up with NLA in a bid to offer its comprehensive suite of virtual care services to benefit the latter's members.
Cigna (CI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Cigna (CI) closed at $218.67, marking a +0.56% move from the previous day.
Top Research Reports for Oracle, Coca-Cola & McDonald's
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Oracle (ORCL), Coca-Cola (KO), and McDonald's (MCD).
Why Retaining Cigna (CI) Stock for Now is a Prudent Move?
by Zacks Equity Research
Cigna (CI) expects growth of at least 350,000 customers in 2021 to ramp up total medical clients.
Cigna (CI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Cigna (CI) closed at $214.94 in the latest trading session, marking a +1.72% move from the prior day.
UnitedHealth's (UNH) Arms Receive Rating Actions From AM Best
by Zacks Equity Research
UnitedHealth's (UNH) subsidiaries get rating upgrades from AM Best. Moreover, outlook of the ratings is revised to stable.
Cigna (CI) Offers MA Plans in Florida, Boosts Provider Network (Revised)
by Zacks Equity Research
Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.
UnitedHealth (UNH) Unit Launches Plan, Boosts Arizona Presence
by Zacks Equity Research
UnitedHealth Group's (UNH) subsidiary UnitedHealthcare unveils The Doctors Plan of Arizona that will offer high-quality and affordable care for two counties in Arizona.
Humana (HUM) Ties Up to Enhance Medicare Advantage Business
by Zacks Equity Research
Humana (HUM) forges an alliance with the Loudoun Medical Group to boost its Medicare Advantage portfolio.
Cigna (CI) Offers MA Plans in Florida, Boosts Provider Network
by Zacks Equity Research
Cigna (CI) announces that it will offer affordable MA plans in two new counties of Florida. Concurrently, CI includes HCA Healthcare to provide a boost to its provider network.
Zacks Industry Outlook Highlights: Cigna Corp, Hartford Financial Services, Prudential Financial, Assurant and Old Republic International Corp
by Zacks Equity Research
Zacks Industry Outlook Highlights: Cigna Corp, Hartford Financial Services, Prudential Financial, Assurant and Old Republic International Corp
7 Multiline Insurers to Watch As Business Activity Gains Momentum
by Tanuka De
Better pricing, product redesigns, technological advancement along with optimistic growth outlook are expected to aid multiline insurers like MET, AIG, CI, HIG, PRU, AIZ and ORI as the impact of the pandemic recedes.